Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Personalized brain stimulation to reduce negative emotions

Official title: Decoding and Modulating Affective Brain States

Run by University of Pennsylvania · NCT05437705 · Data updated 2026-11-12

This study is testing if personalized brain stimulation can help people with negative emotions like anxiety and depression feel better by targeting their specific brain patterns.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment40 (estimated)
SponsorUniversity of Pennsylvania
Academic / other
Locations1 site (Philadelphia, Pennsylvania)
StatusRecruiting
StartedFebruary 21, 2023
Main results expectedDecember 1, 2028
Study endsDecember 1, 2029
Registry record updatedSeptember 3, 2026
Trial IDNCT05437705 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are right-handed adults aged 18-65 with a PHQ-9 score of 10 or higher, indicating moderate to severe depression.

Probably not a fit

Patients with bipolar disorder, schizophrenia, or those who cannot tolerate TMS or MRI scans may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to create personalized brain signatures for individuals experiencing negative emotions such as rumination, major depressive disorder, and anxiety. Participants will undergo a series of MRI scans and assessments to identify their unique negative affect patterns. Following this, they will receive tailored repetitive transcranial magnetic stimulation (rTMS) sessions designed to disrupt these negative patterns. The study involves multiple visits, including behavioral tasks and assessments to evaluate the effectiveness of the stimulation protocols.

Why it matters

Potential benefit: If successful, this approach could lead to more effective treatments for individuals suffering from depression and anxiety by personalizing brain stimulation techniques.

How similar studies have gone: While the use of rTMS has been explored in other studies, this personalized approach using fMRI to tailor stimulation protocols is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion criteria:

1. 18-65 years old
2. Patient Health Questionnaire (PHQ-9 score) = or \> than 10
3. Comprehension of instructions in the English language.
4. Capacity to provide informed consent and follow study procedures.
5. Availability for the duration of the study.

Exclusion Criteria:

1. Diagnosis of bipolar disorder (as PI discretion), schizophrenia or other psychotic disorder
2. Recent use of psychoactive medications or substances as determined by investigators
3. History of neurological disorder or traumatic brain injury (other than mild)
4. Unable to have an MRI scan, or current or prior medical condition that could interfere with the collection or interpretation of MRI data
5. Unable to receive or tolerate TMS
6. Implanted devices, such as an aneurysm clip or cardiac pacemaker
7. History of stroke, epilepsy, or brain scarring
8. Pregnant, nursing, or trying to become pregnant (self-attestation alone)

During this study, participants are asked to:

1. Refrain from substance use (including marijuana and illicit drugs) for duration of the study (self-attestation alone).
2. Abstain from alcohol for 24 hours before the MRI scans (self-attestation alone).
3. Abstain from increasing caffeine intake or begin taking any new medications (self-attestation alone).

Where it's running

  • University of Pennsylvania
    Philadelphia, Pennsylvania, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Readiness and Progress in Emotion Regulation Therapy

    This trial will test if six modules of Emotion Regulation Therapy delivered by telehealth help adults in New York State with high worry, rumination, or self-criticism feel less anxious or depressed and function better.

    Recruiting Teachers College, Columbia University · New York, New York · NCT07478393

  • Single-session intervention to change ambiguity aversion

    This trial tests whether one brief intervention can change how adults with intolerance of uncertainty and anxiety make ambiguous decisions and how their brains respond.

    Recruiting Northwestern University · Chicago, Illinois · NCT06962527

  • One dose of CYB003 for depression and anxiety

    This study tests whether a single dose of CYB003, a psilocin-related compound, can help symptoms in adults with major depressive disorder and anxiety compared to a placebo.

    Recruiting Phase 2 Ohio State University · Columbus, Ohio · NCT06820723

  • Dupilumab for Major Depressive Disorder

    This study tests whether dupilumab can engage immune targets in adults with major depressive disorder to see if it can help with depressive symptoms.

    Recruiting Phase 2 Icahn School of Medicine at Mount Sinai · New York, New York · NCT07908563

  • See if preoperative anxiety affects recovery after major digestive cancer surgery

    This study tests whether anxiety before surgery is linked to more complications after major digestive cancer operations in French-speaking adults.

    Recruiting University Hospital, Rouen · Rouen · NCT07897942

  • Mindful Smartphone Use: A Mindfulness-Based Program for Teens with Sleep and Mood Challenges

    This study tests Mindwire, a mindfulness-based program, to see if it helps teens with problematic phone use who also have depression or anxiety.

    Recruiting Brown University · Providence, Rhode Island · NCT07892807

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.